Neuroprotective effect of ganglioside GM1 on the cytotoxic action of hydrogen peroxide and amyloid β-peptide in PC12 cells

Neurochemical Research

Volumn 32, Issue 8, 2007, Pages 1302-1313

  Sokolova, Tatyana V ^a   Zakharova, Irina O ^a   Furaev, Victor V ^a   Rychkova, Maria P ^a   Avrova, Natalia F ^a  

^a SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

Author keywords

Amyloid peptide; Cell viability; Ganglioside GM1; Hydrogen peroxide; MDA accumulation; Metabolic effects of GM1; Na+,K + ATPase inactivation; Neuroprotective effect; Oxidative stress; PC12 cells

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMYLOID BETA PROTEIN[25-35]; AMYLOID PRECURSOR PROTEIN; GANGLIOSIDE GM1; HYDROGEN PEROXIDE; MALONALDEHYDE;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME INACTIVATION; GENE EXPRESSION; GENE EXPRESSION SYSTEM; GENE MUTATION; GENETIC TRANSFECTION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; CARBAZOLES; CATTLE; CELL SURVIVAL; ENZYME INHIBITORS; G(M1) GANGLIOSIDE; HUMANS; HYDROGEN PEROXIDE; INDOLE ALKALOIDS; NEUROPROTECTIVE AGENTS; OXIDANTS; OXIDATIVE STRESS; PC12 CELLS; PEPTIDE FRAGMENTS; RATS; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 34250851727     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9304-2     Document Type: Article

References (42)

1. Fighera MR, Bonini JS, de Oliveira TG et al (2003) GM1 ganglioside attenuates convulsions and thiobarbituric acid reactive substances production induced by intrastriatal injection of methylmalonic acid. Int J Biochem Cell Biol 35:465-473
2. Choi JS, Kim JA, Joo CK (2003) Activation of MAPK and CREB by GM1 induces survival of RGCs in the retina with axotomized nerve. Invest Ophthalmol Vis Sci 44:1747-1752
3. Bachis A, Mocchetti I (2006) Semisynthetic sphingoglycolipid LIGA20 is neuroprotective against human immunodeficiency virus-gp120-mediated apoptosis. J Neurosci Res 83:890-896
4. Hadjiconstantinou M, Neff NH (1998) GM1 ganglioside: in vivo and in vitro trophic actions on central neurotransmitter systems. J Neurochem 70:1335-1345
5. Avrova NF, Victorov IV, Tyurin VA et al (1998) Inhibition of glutamate-induced intensification of free radical reactions by gangliosides: possible role in their protective effect in rat cerebellar granule cells and brain synaptosomes. Neurochem Res 23:945-952
6. +)-ATPase in cortical focal ischemia: GM1 ganglioside protects plasma membrane structure and function. J Neurosci Res 32:209-220
7. Sautter J, Hoglinger GU, Oertel WH et al (2000) Systemic treatment with GM1 ganglioside improves survival and function of cryopreserved embryonic midbrain grafted to the 6-hydroxydopamine-lesioned striatum. Exp Neurol 164:121-129
8. Geisler FH, Coleman WP, Grieco G et al (2001) The Sygen multicenter acute spinal cord injury study. Spine 26(Suppl 24):S87-98
9. Candelise L, Ciccone A (2002) Gangliosides for acute ischemic stroke. Stroke 33:2336
10. Becker D, Sadowsky CL, McDonald JW (2003) Restoring function after spinal cord injury. Neurologist 9:1-15
11. Wahlgren NG, Ahmed N (2004) Neuroprotection in cerebral ischemia: facts and fancies - the need for new approaches. Cerebrovasc Dis 17(Suppl 1):153-166
12. Augustinsson LE, Blennow K, Blomstrand C et al (1997) Intracerebroventricular administration of GM1 ganglioside to presenile. Alzheimer patients. Dement Geriatr Cogn Disord 8:26-33
13. Svennerholm L, Brane G, Karlsson I et al (2002) Alzheimer disease - effect of continuous intracerebroventricular treatment with GM1 ganglioside and a systematic activation programme. Dement Geriatr Cogn Disord 14:128-136
14. Matsuoka Y, Saito M, LaFrancois J et al (2003) Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta amyloid. J Neurosci 23:29-33
15. Ariga T, Yu RK (1999) GM1 inhibits amyloid beta-protein-induced cytokine release. Neurochem Res 24:219-226
16. Kakio A, Nishimoto S, Yanagisawa K et al (2002) Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Biochemistry 41:7385-7390
17. Yamamoto N, Igbabvoa U, Shimada Y et al (2004) Accelerated Abeta aggregation in the presence of GM1-ganglioside-accumulated synaptosomes of aged apoE4-knock-in mouse brain. FEBS Lett 569:135-139
18. 1-40 peptide in a membrane mimic environment. Neurochem Res 29:447-453
19. Vassault A (1983) Lactate dehydrogenase: UV-method with pyruvate and NADH. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Verlag Chemie, Weinheim vol 3, pp 118-126
20. Porter NA, Nixon J, Isaac R (1976) Cyclic peroxides and the thiobarbituric assay. Biochim Biophys Acta 441:506-512
21. +-ATP-ase by nanomolar concentrations of GM1 ganglioside. J Neurochem 37:350-357
22. Tyurin VA, Tyurina YuYu, Avrova NF (1992) Ganglioside-dependent factor, inhibiting lipid peroxidation in rat brain synaptosomes. Neurochem Int 20:401-407
23. Rauvala H (1979) Monomer-micelle transition of the ganglioside GM1 and the hydrolysis by Clostridium perfringes neuraminidase. Eur J Biochem 97:555-564
24. Ulrich-Bott B, Wiegandt HJ (1984) Micelle properties of glycosphingolipids in aqueous media. Lipid Res 25:1233-1245
25. Saqr HE, Pearl DK, Yates AJ (1993) A review and predictive models of ganglioside uptake by biological membranes. J Neurochem 61:395-411
26. Marques C, Keil U, Bonert A et al (2003) Neurotoxic mechanisms caused by Alzheimer's disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway. J Biol Chem 278:28294-28302
27. Ferrari G, Anderson BL, Stephen RM et al (1995) Prevention of apoptotic neuronal death by GM1 ganglioside. Involvement of Trk neurotrophin receptors. J BiolChem 270:3074-3080
28. Ferrari G, Greene LA (1998) Promotion of neuronal survival by GM1 ganglioside. Phenomenology and mechanism of action. Ann NY Acad Sci 845:263-273
29. Arcuri C, Bianchi R, Brozzi F et al (2005) S100B Increases proliferation in PC12 neuronal cells and reduces their responsiveness to nerve growth factor via Akt activation. J Biol Chem 280:4402-4414
30. Ferrari G, Batistatou A, Green LA (1993) Gangliosides rescue neuronal cells from death after trophic factor deprivation. J Neurosci 13(5):1879-1887
31. Schubert D, Kimura H, Maher P (1992) Growth factors and vitamin E modify neuronal glutamate toxicity. Proc Natl Acad Sci USA 89:8264-8267
32. Ochiai T, Ohno S, Soeda S et al (2004) Crocin prevents the death of rat pheochromocytoma (PC12) cells by its antioxidant effects stronger than those of alpha-tocopherol. Neurosci Lett 362:61-64
33. Shearman MS, Ragan CI, Iversen LL (1994) Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid cell death. Proc Natl Acad Sci 91:1470-1474
34. Jang JH, Surh YJ (2003) Protective effect of resveratrol on β-amyloid-induced oxidative PC12 cell death. Free Radical Biol Med 24:1100-1110
35. Rogers J, Strohmeyer R, Kovelowski CJ et al (2002) Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia 40:260-269
36. Eckert A, Steiner B, Marques C et al (2001) Elevated vulnerability to oxidative stress-induced cell death and activation of caspase-3 by the Swedish amyloid precursor protein mutation. J Neurosci Res 64:183-192
37. Avrova NF, Zakharova IO, Tyurin VA et al (2002) Different metabolic effects of ganglioside GM1 in brain synaptosomes and phagocytic cells. NeurochemRes 27:751-759
38. +-ATP-ase activity inhibition and oxidative stress induced by glutaric acid and pentylenetetrazole. Neurobiol Dis 22:611-623
39. +-ATPase activity in hippocampal neurons. Brain Res 756:205-214
40. Duchemin AM, Ren Q, Mo L et al (2002) GM1 ganglioside induces phosphorylation and activation of Trk and Erk in brain. J Neurochem 81:696-707
41. Singleton DW, Lu CL, Colella R et al (2000) Promotion of neurite outgrowth by protein kinase inhibitors and ganglioside GM1 in neuroblastoma cells involves MAP kinase ERK1/2. Int J Dev Neurosci 18:797-805
42. Mo L, Ren Q, Duchemin AM et al (2005) GM1 and ERK signaling in the aged brain. Brain Res 1054:125-134